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Gestational diabetes prevalence and risk 
factors among pregnant women  
— Jazan Region, Saudi Arabia
ABSTRACT
Background. The gestational diabetes (GDM) is con-
sidered as a global public health problem that affects 
pregnant women. GDM can become chronic type II 
and usually it is associated with many risk factors that 
may lead to many serious complications for the mother 
and the fetus. The main objective of this study was 
to estimate the prevalence of GDM among pregnant 
women in Jazan region and to determine the possible 
associated factors of the GDM. 
Material and methods. The study involved pregnant 
women attending department of Obstetrics and Gy-
necology at government hospitals of Jazan region. 
A sample of 440 pregnant women were randomly 
selected. Interviews were conducted using a question-
naire prepared to measure the GDM prevalence, risk 
factors, awareness and adherence to the advice of the 
doctor and medications. 
Results. The prevalence of gestational diabetes among 
pregnant women in Jazan is estimated at 8.2%. The 
GDM prevalence was significantly higher among obese 
women (20.2%; 95% CI 13.2–29.2) compared with 
women with normal weight (7.1%; 95% CI 1.7–7.6). 
The analysis showed that GDM was significantly asso-
ciated with child weight more than 3.5 kg (OR 4.315; 
p = 0.004), mother’s BMI more than 30 kg/m2 
(OR 4.703; p = 0.001), and family history of GDM 
(OR 2.606; p = 0.046). 
Conclusion. In conclusion, the GDM prevalence ob-
tained in this study is more than global prevalence 
and less than other studies in KSA. The BMI of mothers 
and having neonates that weight more than 3.5 kg are 
the main risk factors for GDM. Suitable interventions 
programs are highly required for control and risk fac-
tor modifications. (Clin Diabetol 2017; 6, 5: 172–177)
Key words: gestational diabetes, obstetrics, 
hypoglycemia, Jazan
Introduction 
Gestational diabetes is known as any degree of 
glucose intolerance with onset or first recognition dur-
ing pregnancy. GDM causes high blood sugar that may 
affect the pregnancy and its outcome. Uncontrolled 
diabetes in early pregnancy leads to higher incidence 
of congenital anomalies of the fetus such as ventricu-
lar septal defect (VSD), neural tube defects (NTD) and 
Caudal Regression Syndrome (CRS) [1]. 
In the late pregnancy, uncontrolled diabetes leads 
to over-weight of fetus. Complications in fetus extends 
to fetal macrosomia, neonatal morbidity and mortality 
due to congenital anomalies, excessive fetal growth, 
respiratory distress syndrome, neonatal hypoglycemia 
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and hypocalcemia, hypomagnesaemia, hyper biliru-
binemia and polycythemia [2]. 
In most cases, gestational diabetes does not have 
symptoms, but increased urination, fatigue, nausea, 
vomiting, bladder infection and yeast infections can 
sometimes be present [3]. Poorly controlled glycaemia 
during pregnancy may lead to one of the followings 
complication of mother: abortion, poly-hydramnios, 
preterm labor, pre-eclampsia, placenta praevia, pruritus 
vulvae, urinary tract infection, puerperal sepsis and 
pyelonephritis [4]. 
The global profile of GDM suggests increasing 
prevalence during the past two decades, with large 
variabilities between different countries [5]. The es-
timated prevalence of GDM in many studies ranges 
between (1–20%) [6]. Some of developed countries, 
like Canada has low prevalence of GDM of only 2.5% 
in 2001 which increased to 54.5 per 1,000 deliveries 
in 2010 [7, 8]. In the USA, the prevalence ranges 3.9% 
to 12.8% [5]. In India study showed the prevalence of 
GDM is about 6.6% [9]. In the Qatar in 2010, study 
showed that the prevalence of GDM is about 16.3% 
[10]. The prevalence of GDM in Saudi Arabia ranges 
from 12.5% to 22.1% [11]. 
Different types of studies conducted in the differ-
ent parts of the world to identify the main risk factors 
responsible for GDM. These studies summarized the 
risk factor to be: age above 35 years, overweight or 
obese women, recurrent abortion, neonatal death, 
pre-eclampsia, history of diabetes, high birth weight, 
caesarian section, multiple previous pregnancy [12, 13]. 
Many studies have been conducted in different 
parts of Saudi Arabia to examine the profile of GDM 
among pregnant women, but to our best of knowledge 
no previous study has been conducted in Jazan region. 
The main objectives of this study were to measure the 
prevalence of GDM among pregnant women in Jazan 
region and to determine the possible associated fac-
tors of GDM.
Research methods
Study area, design and population 
This study was conducted in three selected gene-
ral hospitals in Jazan region namely; Jazan general 
hospital, Abuarish general hospital and Sabya general 
hospital. Jazan region is located in the Southwest Saudi 
Arabia. It is one of the 13 regions of Saudi Arabia and 
populated with approximately 1.5 million population. 
Observational cross-sectional study was conducted to 
measure prevalence and risk factor of GDM among 
pregnant women attending obstetrics and gyneco -
logy departments in the selected three hospitals. The 
survey selected pregnant women in the reproductive 
age (15–49) in the 2nd and 3rd trimester during No-
vember 2014.
Sampling method and sample size 
The proposed sample size for this study was cal-
culated to be 440. The calculation of the sample size 
was conducted on the assumptions that confidence 
level (95%), margin of error not more than (5%) and 
prevalence of GDM about (50%), as no previous study 
is available in the region and finally non-response rate 
of 10%. 
Procedures 
Generally, at the first antenatal visit, fasting plasma 
glucose (FPG), glycated hemoglobin (HbA1c), and ran-
dom plasma glucose were obtained from the pregnant 
women (initial screenings). Overt diabetes in preg-
nancy is diagnosed if; FPG ≥ 7.0 mmol/L (126 mg/dL) 
or HbA1c > 6.5 or random plasma glucose ≥ 11.1 
mmol/L (200 mg/dL) plus confirmation. Screening of 
gestational diabetics for the women include one hour 
50 g glucose challenge test (GCT), which is considered 
as the best method of screening, where patient usually 
not fasting prescribed oral 50 grams glucose. Blood 
sugar then measured, if < 7.8 mmol (< 140 gms.), is 
considered normal. In case of GCT is normal, the test 
will be repeated at 24–28 weeks. If abnormal screening 
results > 140 mg, the patient is to have the diagnostic 
test which is oral glucose tolerance test. Diagnostic 
OGTT can be done either with 100-g and 3 hours test 
or with 75 g and 2-hours test. Women who have had 
gestational diabetes in a previous pregnancy should 
be offered early self-monitoring of blood glucose or an 
OGTT at 16–18 weeks, and a further OGTT at 28 weeks if 
the results are normal. All pregnant patients attending 
for OGTT are instructed to fast from 12 midnight on 
the evening before their appointment [13].
Data collection and study instrument
The data was collected by interview “face to face” 
using a questionnaire designed for the purpose of the 
study. The questionnaire included open and closed 
ended questions, there were 25 questions classified 
into four parts personal data, prevalence and risk fac-
tors that leading to GDM, awareness about GDM and 
management of GDM. We conducted a pilot study by 
distributing 20 questionnaires and the main objective 
of this pilot test was to assess the components of the 
questionnaire, the understanding of study respondent 
about the questions and the time needed to answer 
the questionnaire.
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Statistical analysis 
The overall GDM-prevalence among the study par-
ticipants was calculated using 95% confidence intervals 
(CI). The chi-square test or Fisher’s exact test was used 
to evaluate the GDM-prevalence among the different 
sub-groups. Crude odds ratios (ORs) were obtained 
by univariate analysis to determine the association of 
each variable with GDM. All statistical tests were two-
sided; and a p < 0.05 was considered significant. The 
statistical analysis was performed using SPSS ver. 17.0 
(SPSS Inc. Chicago, IL, USA) software.
Ethical considerations
Ethical approval for this study was obtained from 
the Ethics Committee of the Faculty of Medicine, Jazan 
University. Informed written consent was obtained 
from all participants prior to involvement in the study. 
Results 
Study participants including 440 females from the 
general hospitals (Sabya, Jazan, Abuarish). The majority 
of women were in the age group (21–25) and (26–30) 
years, 33.0% and 30.9% respectively. Nearly half of the 
women (48.9%) are with high school education level. 
The large portion of women are women with normal 
body weight (40%), obese were (27.9%), while women 
in third trimester were (70%) (Table 1).
Table 2 shows the prevalence GDM among preg-
nant women in Jazan region. The overall prevalence 
of GDM in Jazan region was 8.2% and significantly 
higher among those > 31–35 years old. Prevalence was 
also significantly higher among obese women (20.2%; 
95% CI 13.2–29.2) compared with women with normal 
weight (7.1%; 95% CI 1.7–7.6). The prevalence of GDM 
among working women was (8.3%; 95% CI 29.8–49.7) 
versus non-working (8.1%; 95% CI,2.7–7.9) and Saudi 
(8.6%; 95% CI 4.2–16.2) versus non-Saudi population 
(5.4%; 95% CI 5.7–11.4). 
Table 3 shows the association between certain 
factors and GDM prevalence among pregnant women 
in Jazan population. The prevalence was significantly 
associated with family history of GDM, child weight 
greater than 3.5 kg, mother’s BMI greater than 
30. No significant association was found between 
GDM prevalence and number of pregnancies more 
than three children and mother’s age greater than 
35 years.
Table 4 illustrates the results of the multivariate 
logistic regression analysis. The analysis showed that 
GDM prevalence was significantly associated with child 
weight more than 3.5 kg (OR 4.315; p = 0.004), moth-
er’s BMI more than 30 kg/m2 (OR 4.703; p = 0.001), 
and family history of GDM (OR 2.606; p = 0.046). 
Figure 1 presents some variables related to GDM 
management among pregnant women with GDM. 
According to the figure, 81% of women were well 
adherent to doctor advice. The same figure lustrates 
that about one third of women were practicing exercise 
(34%). Seventy percent of the women were following 
proper diet, while 44% are regular checking up their 
blood sugar level at home. 
Discussion
Our paper suggests that the prevalence of GDM is 
estimated at 8.2% (95% CI 6.0–11.1), which is lower 
that most studies conducted in Saudi Arabia [6, 14, 
15]. Literature generally suggested high variability of 
GDM, this may be attributed to discrepancies in GDM 
prevalence estimates by data sources and for a consen-
sus on which diagnostic criteria to use. 
Our study revealed that the prevalence of GDM was 
higher among women in the age group (31–35) years. 
Many studies suggested that it is normally high among 
Table 1. Demographic profile of the study population


















Not working 356 80.9
BMI categories
Underweight 47 10.8




Second trimester 4–5–6 131 29.8
Third trimester 7–8–9 308 70.2
Total 440 100
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age groups higher than 35 years [7, 10, 11, 16–19]. The 
prevalence of GDM distribution by educational levels 
showed that it is high among women with intermediate 
educational level, this somehow different from other stud-
ies like Bangladesh study, where GDM was found to be 
higher among women with higher education level [17].
Regarding the risk factors of gestational diabetes, 
we found a significant association between obesity 
Table 3. Risk factors associated with GDM among pregnant women Jazan, Saudi Arabia
Factor N (%) GDM positive N (%) GDM negative OR (95% CI) P-value
Family history of GDM (n = 440)
Yes 15 (17.9) 69 (82.1) 3.50 (1.70–7.1) 0.000
No 21 (5.9) 335 (94.1)
Child weight (n = 306)
More than 3.5 kg 10 (25.0) 30 (75.0) 5.5 (2.3–16.2) 0.000
Less than 3.5 kg 15 (5.6) 251 (94.4)
Number of Pregnancies (n = 440)
3 or less 21 (7.2) 271 (92.8) 1.03 (0.97–1.10) 0.287
More than 3 15 (10.1) 133 (89.9)
Mother’s BMI (n = 440)
Less than 29.9 kg/m2 18 (5.2) 329 (94.8) 1.17 (1.01–1.3) 0.000
30 kg/m2 and above 18 (19.4) 75 (80.6)
Mother’s age (n = 440)
Less than 35 years 32 (7.9) 373 (92.1) 1.04 (0.92–1.17) 0.465
35 years and more 4 (11.4) 31 (88.6)
Table 2. Prevalence of GDM among pregnant women in Jazan, Saudi Arabia
Characteristic GDM positive/ N-tested Prevalence 95% CI P-value
Age group (years)
15–20 (6/48) 12.5 (5.9–24.8) 0.033
21–25 (3/145) 2.1 (0.8–5.9)
26–30 (13/136) 9.6 (5.7–15.7)
31–35 (10/76) 13.2 (7.3–22.6)
36–50 (4/35) 11.4 (4.7–26.0)
Educational level
None (2/41) 4.9 (1.5–16.2) 0.011
Primary (3/49) 6.1 (2.2–16.5) 
Intermediate (8/42) 19.0 (16.0–33.4) 
Secondary (12/93) 12.9 (7.5–21.2) 
High school (11/215) 5.1 (2.9–8.9) 
Work status
Working (7/84) 8.3 (29.8–49.7) 0.550
Not working (29/356) 8.1 (2.7–7.9)
Nationality
Saudi (33/384) 8.6 (4.2–16.2) 0.300
Non-Saudi (3/56) 5.4 (5.7–11.4)
BMI [kg/m2]
Underweight (3/26) 16.4 (4.2–29.1) 0.000
Normal weight (6/166) 7.1 (1.7–7.6)
Overweight (9/150) 6.0 (3.2–11.0)
Obesity (18/89) 20.2 (13.2–29.2)
Overall prevalence (36/440) 8.2 (6.0–11.1)
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and GDM, also history of diabetes, high birth weight 
and ageing. Comparing with other studies conducted 
in Canada, Sirlanka and Italy, we found similar or close 
results to our study [7, 12, 19].
The percentage of pregnant women who were 
following diet advice was 70.0% of the GDM mothers, 
while the percentage of GDM women who are adherent 
to instructions of doctors is 81.0%. Also, the percent-
age of pregnant women who are performing exercise 
is 34.0%. Life style change is very important for women 
with GDM, as studies showed that changing life style 
decreases the probability of type 2 DM among GDM 
women [20]. Shek, et al. 2014 in their randomized in-
tervention study showed that lifestyle intervention can 
reduce the development of type 2 DM and metabolic 
syndrome among Chinese women who had GDM. 
Our study has some limitations; first as participants 
of this study were limited to women attending general 
hospitals of Jazan region, the results may only apply to 
women visiting general hospitals of the same profile. 
The cross-sectional nature of the study is another limita-
tion, associations from this study should be understood 
with in this context. However, to our best knowledge 
the present study is the first study investigating the 
issue of GDM in Jazan region and the study outcomes 
supposed to provide a quick picture about the situation 
of GDM in the area.
Conclusion and recommendations
In conclusion, the GDM prevalence obtained in this 
study is 8.2%, which is more than global prevalence 
and less than other cities in KSA. The body mass index 
of mothers and having neonates that weight more 
than 3.5 kg are the main risk factors for gestational 
diabetes mellitus in Jazan region. Given what we have 
mentioned, we strongly recommend increase of women 
awareness about GDM and promoting a healthy life- 
-style interventions for preventing GDM and improving 
pregnant women quality of life. 
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